If you've spent any time reading about kratom, you've seen the word mitragynine. It shows up on certificates of analysis, in research papers, in vendor marketing, in Reddit debates about which strain is "stronger." Most explanations either skip the science entirely or drown new readers in terminology that requires a chemistry degree to parse.
We're going to do something different. This guide explains what mitragynine actually is, how it works in the body, why it matters when you're shopping for kratom, and what the research says (and doesn't say). No pretending it's simple when it isn't, and no jargon for the sake of jargon.
By the end you'll understand why mitragynine percentages on a COA mean what they mean, why some strains feel different from others, and what to actually do with that knowledge as a kratom user.
Table of Contents
- What Mitragynine Actually Is
- How Mitragynine Works in the Body
- The Mitragynine vs 7-Hydroxymitragynine Relationship
- Why Mitragynine Content Varies Across Strains and Products
- What Research Says (and Doesn't Say) About Mitragynine
- Practical Implications for Kratom Users
TL;DR
- Mitragynine is the most abundant active compound in kratom, making up 60-75% of total alkaloids in most strains
- It's the primary driver of most felt effects at typical doses, including pain relief, energy, mood, and relaxation
- 7-hydroxymitragynine is a related minor alkaloid, present in trace amounts but significantly more potent per milligram
- Mitragynine percentages typically range from 0.5% to 1.5% of dry leaf weight, varying by strain, harvest, and processing
- Quality vendors publish mitragynine content per batch; comparing in milligrams is the only reliable way to compare across products
What Mitragynine Actually Is
Mitragynine is an indole alkaloid, which is a category of plant-derived nitrogen-containing compounds that includes hundreds of biologically active molecules across different species. In the kratom plant (Mitragyna speciosa), mitragynine is the most abundant active compound by far.
The Chemistry in Plain Terms
The molecular formula is C23H30N2O4. What matters in plain language is that mitragynine is a complex molecule built around a tryptophan-derived backbone, the same biochemical starting point used to make serotonin, melatonin, and several plant alkaloids you've heard of like psilocybin and yohimbine. Its structure includes elements that allow it to interact with multiple receptor types in the human body, which is why kratom produces effects across so many different categories instead of just one.
The compound was first isolated in 1907 by Dutch researcher D. Hooper, then further characterized through the 1960s. According to a comprehensive review on PubMed Central covering kratom pharmacology, mitragynine and 7-hydroxymitragynine are the most studied active components and account for the majority of the plant's pharmacological activity. (Source)
Where It Lives in the Plant
Mitragynine is concentrated primarily in kratom leaves. The exact mitragynine content in fresh leaves depends on the tree's age, climate, soil chemistry, and even the time of day the leaves were picked. This is why the same strain harvested from two different farms can test with meaningfully different mitragynine percentages.
The Concentration Range You'll See
For commercial kratom powder, mitragynine content typically falls between 0.5% and 1.5% of dry leaf weight. So a gram of dried kratom leaf contains roughly 5 to 15 milligrams of mitragynine. When you see a COA listing mitragynine at 1.2%, that means 12 milligrams of every gram is the active mitragynine compound.
How Mitragynine Works in the Body
The Receptor Story
Mitragynine interacts with several receptor systems. The most studied is the mu-opioid receptor system, where mitragynine acts as a partial agonist. A full agonist activates a receptor to maximum capacity (morphine and oxycodone do this). A partial agonist binds the same receptor but only activates it to a fraction of maximum capacity. Mitragynine's partial agonism produces analgesic and relaxing effects without the full opioid pharmacology profile of opiates. The 2022 paper in Frontiers in Pharmacology details this distinction in technical depth. (Source)
Beyond mu-opioid receptors, mitragynine also interacts with delta and kappa opioid receptors at lower affinity, plus alpha-2 adrenergic receptors and serotonin receptors. This multi-receptor profile is why kratom's effects feel different from straight opioids.
The Practical Effect Chain
- Mitragynine is absorbed through the gut wall, primarily in the small intestine
- The liver metabolizes a portion into 7-hydroxymitragynine via CYP3A4 and CYP2D6 enzymes
- Both compounds circulate and cross the blood-brain barrier
- Mitragynine binds to mu-opioid receptors and other targets, producing felt effects
- Effects peak roughly 30 to 90 minutes after consumption and last 4 to 6 hours
Why Effects Vary Person to Person
The CYP2D6 and CYP3A4 enzyme variants you inherited matter more than people realize. Some users metabolize mitragynine slowly, leading to longer-lasting effects from smaller doses. Others have fast variants that clear it more quickly.
The Mitragynine vs 7-Hydroxymitragynine Relationship
What 7-Hydroxymitragynine Is
7-hydroxymitragynine (often abbreviated 7-OH) is a related alkaloid structurally similar to mitragynine but with an additional hydroxyl group at the 7-position. That small structural change makes 7-OH significantly more potent at mu-opioid receptors. In raw kratom leaf, 7-OH is present in trace amounts (under 0.05% of dry weight), but the per-milligram potency is much higher.
Why the Ratio Matters
Some research suggests the ratio of mitragynine to 7-OH influences the qualitative experience of kratom. Strains with slightly elevated 7-OH tend to feel more relaxing. Strains with lower 7-OH proportions feel more stimulating. The 2020 PubMed Central study tracking long-term user surveys found qualitative differences across vein colors consistent with the ratio model. (Source)
The 7-OH-Only Product Concern
A growing category of products sells extracted or synthesized 7-hydroxymitragynine in concentrations far above what's found naturally in kratom. These approach the potency of full opioid agonists, which means dependence and withdrawal risks climb steeply. The FDA has flagged some of these products as having significant safety concerns. (Source)
Why Mitragynine Content Varies Across Strains and Products
Vein Color and Maturity
Younger leaves harvested early test lower in mitragynine and lean white vein. Mature leaves harvested later test higher and lean red vein. Green vein sits in the middle.
Drying Method
Sun-drying tends to convert some mitragynine into related alkaloids and 7-OH. Indoor drying preserves more mitragynine in its original form. Different drying methods produce meaningfully different final chemistry.
Strain Selection
"Maeng da" is a Thai term meaning premium-selected. A genuine maeng da product should test on the higher end of the mitragynine range (1.2-1.6% mitragynine is realistic). Our kratom strain chart maps the relationships across vein colors and origins.
Storage and Freshness
Mitragynine degrades with time, light, heat, oxygen, and humidity. A bag that tested at 1.4% might test at 1.0% six months later if stored poorly. Proper storage (airtight, dark, cool, dry) preserves mitragynine for 3 to 6 months at full potency.
Comparing Across Products
The only reliable comparison is mitragynine content in milligrams per serving. Vendor claims like "4x stronger" mean nothing without numbers.
What Research Says (and Doesn't Say) About Mitragynine
What Research Has Established
- Mitragynine is the dominant active alkaloid and accounts for most felt effects at typical doses
- Mitragynine acts as a partial agonist at mu-opioid receptors with secondary multi-receptor activity
- Long-term heavy use can produce dependence and withdrawal, typically milder than traditional opioids
- Metabolized primarily through CYP3A4 and CYP2D6 liver enzymes
- High-dose use carries risks including nausea, sedation, respiratory depression at very high doses
What's Still Being Studied
- Long-term cognitive effects are not fully characterized
- The exact mechanism by which alkaloid ratios produce different qualitative effects is partially understood
- Therapeutic potential for chronic pain and opioid use disorder is being studied but not conclusive
- Optimal dose ranges for therapeutic vs recreational use are not well-defined
What the Honest Statement Looks Like
According to the National Center for Complementary and Integrative Health, kratom and its alkaloids require more research before clinical recommendations can be made, and consumers should approach kratom with the same caution they'd apply to any unregulated psychoactive substance. (Source) Our article on kratom tolerance walks through the receptor-level mechanism in lay terms.
Practical Implications for Kratom Users
Read COAs Like You Mean It
The number to focus on is mitragynine percentage by dry weight, or mitragynine in milligrams per serving for capsules and extracts. A COA that says "mitragynine: 1.4%" tells you each gram contains 14 mg of mitragynine. A 3-gram dose at 1.4% = 42 mg.
Track Your Total Daily Mitragynine Intake
- Morning: 2 g of 1.2% mitragynine powder = 24 mg
- Afternoon: 1 capsule with 30 mg mitragynine extract = 30 mg
- Evening: 2 g of 1.3% red maeng da = 26 mg
- Total daily intake: 80 mg mitragynine
Most users feel best staying under 200 mg of total daily mitragynine. Going above 300 mg daily is where dependence risk climbs noticeably.
Match the Strain to the Effect, Not the Hype
Higher mitragynine + lower 7-OH skews stimulating. Lower mitragynine + higher 7-OH skews relaxing. Premium strains typically test higher in total alkaloid load. Our kratom dosage guide walks through the day-by-day protocol.
Quality Signals That Actually Matter
- Recent COA (within 6 months) listing actual mitragynine percentage
- Heavy metals and microbial testing alongside alkaloid testing
- Batch number on packaging matching the COA batch
- Country of origin and harvest date listed clearly
- AKA GMP qualification (imperfect filter but useful baseline)
GRH Kratom publishes a current COA on every batch with mitragynine percentages clearly listed. Green Vein collection, Red Vein collection, and Premium Extracts and start with a single-serving size.
Final Thoughts
Mitragynine is the molecule doing most of the work in your kratom. Understanding what it is, how it works, and what the numbers on a COA actually mean turns kratom from a guessing game into something you can actually optimize.
The biggest takeaway: mitragynine percentages are the only reliable cross-product comparison metric, milligrams of mitragynine per dose is the most useful daily tracking variable, and strain marketing only makes sense once you know how to read the underlying numbers.
For users who want to apply this in practice: start with lab-tested products, learn to read COAs, track daily intake in milligrams, and respect tolerance signals. Those four habits separate the users who get long-term benefit from kratom from the users who burn out chasing weaker and weaker effects.
The science isn't complete. The marketing often isn't honest. But the part you can control, the dose you take and the product you choose, is grounded in real numbers that any user can learn to read.
